Jeil Pharmaceutical Co Ltd (271980) – Strategy, SWOT and Corporate Finance Report

Jeil Pharmaceutical Co Ltd (271980) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Jeil Pharmaceutical Co Ltd (Jeil), is a pharmaceutical company which carries out research, development, manufacturing and commercialization of active pharmaceuticals and finished dosage forms. Its product portfolio includes solid medicines and injections, finished pharmaceutical products including patches and active pharmaceutical ingredients (APIs). The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others. Jeil exports synthetic ingredients such as Cefditoren Pivoxil and Epinastine HCl, among others to Japan and China. It also exports over the counter products such as Kefentech Plaster and Sanyplast in ASEAN countries, Central and South America, Africa, and other countries. The company operates a factory and research and development institute in Yongin-si, Gyeonggi-do, Korea. Jeil is headquartered in Seoul, South Korea.

Scope

• Detailed information on Jeil Pharmaceutical Co Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Jeil Pharmaceutical Co Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Jeil Pharmaceutical Co Ltd including a breakdown and examination of key business segments

• News about Jeil Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Jeil Pharmaceutical Co Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Jeil Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Jeil Pharmaceutical Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Chong Kun Dang Holdings Corp

Kyung Dong Pharmaceutical Co Ltd

Daewoong Pharmaceutical Co Ltd

Ilsung Pharmaceutical Co Ltd

Ildong Pharmaceutical Co Ltd

Seoul Pharma Co Ltd

Daewoong Pharmaceutical Co Ltd

Seoul Pharma Co Ltd

Ilsung Pharmaceutical Co Ltd

Ildong Pharmaceutical Co Ltd

Kyung Dong Pharmaceutical Co Ltd

Chong Kun Dang Pharmaceutical Corporation

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Jeil Pharmaceutical Co Ltd - Key Facts

Jeil Pharmaceutical Co Ltd - Key Employees

Jeil Pharmaceutical Co Ltd - Major Products and Services

Jeil Pharmaceutical Co Ltd - History

Jeil Pharmaceutical Co Ltd - Company Statement

Jeil Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Jeil Pharmaceutical Co Ltd - Business Description

R&D Overview

Jeil Pharmaceutical Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Jeil Pharmaceutical Co Ltd - Strengths

Jeil Pharmaceutical Co Ltd - Weaknesses

Jeil Pharmaceutical Co Ltd - Opportunities

Jeil Pharmaceutical Co Ltd - Threats

Jeil Pharmaceutical Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Jeil Pharmaceutical Co Ltd, Recent Deals Summary

Section 5 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Jeil Pharmaceutical Co Ltd, Key Facts

Jeil Pharmaceutical Co Ltd, Key Employees

Jeil Pharmaceutical Co Ltd, Major Products and Services

Jeil Pharmaceutical Co Ltd, History

Jeil Pharmaceutical Co Ltd, Other Locations

Jeil Pharmaceutical Co Ltd, Subsidiaries

Jeil Pharmaceutical Co Ltd, Key Competitors

Jeil Pharmaceutical Co Ltd, Ratios based on current share price

Jeil Pharmaceutical Co Ltd, Annual Ratios

Jeil Pharmaceutical Co Ltd, Annual Ratios (Cont…1)

Jeil Pharmaceutical Co Ltd, Annual Ratios (Cont…2)

Jeil Pharmaceutical Co Ltd, Interim Ratios

Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Jeil Pharmaceutical Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Jeil Pharmaceutical Co Ltd, Performance Chart (2018 – 2022)

Jeil Pharmaceutical Co Ltd, Ratio Charts

Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports